Carotid artery intima-media thickness in elderly patients with NIDDM and in nondiabetic subjects

Stroke

Volumn 27, Issue 11, 1996, Pages 1986-1992

  Niskanen, Leo ^a   Rauramaa, Rainer ^a   Miettinen, Heikki ^a,b   Haffner, Steven M ^b,d   Mercuri, Michele ^c   Uusitupa, Matti ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b Mays Cancer Center at UT Health San Antonio   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

aged; apolipoproteins; carotid artery diseases; diabetes mellitus; ultrasonics

Indexed keywords

ADULT; AGED; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD VESSEL DIAMETER; CAROTID ARTERY OBSTRUCTION; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

EID: 0029825372     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.27.11.1986     Document Type: Article

References (42)

1. Pyörälä K, Laakso M, Uusitupa M. Diabetes and atherosclerosis: an epidemiological view. Diabetes Metab Rev. 1987;2:463-524.
2. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607.
3. Uusitupa MIJ, Niskanen LK, Siitonen O, Voutilainen E, Pyörälä K. Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia. 1993;36: 1175-1184.
4. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimai plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation. 1986;74:1399-1406.
5. Wong M, Edelstein J, Wollman J, Bond G. Ultrasonic-pathological comparison of the human arterial wall: verification of intima-media thickness. Arterioscler Thromb. 1993;13:482-486.
6. Bond MG, Barnes RW, Riley WA, Wilmoth SK, Chambless LE, Howard G, Owens B, for the ARIC Study Group. High resolution B-mode ultrasound scanning methods in communities study (ARIC). J Neuroimaging. 1991;1:68-72.
7. Mercuri M, Bond MG, Nichols FT, Carr AA, Flack JM, Byington R, Raines J, for the MIDAS Group. Baseline reproducibility of B-mode ultrasound imaging measurements of carotid intimal media thickness: the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). J Cardiovasc Diagnosis Procedures. 1993;11:241-252.
8. Craven TE, Ryu JE, Espeland MA, Kahl FR, McKinney WM, Toole JF, McMahon MR, Thompson CJ, Heiss G, Crouse JR. Evaluation of the associations between carotid artery atherosclerosis and coronary artery stenosis. Circulation, 1990;82:1230-1242.
9. Wofford JL, Kahl FR, Howard GR, McKinney WM, Toole JF, Crouse JR. Relation of extent of extracranial carotid artery atherosclerosis as measured by B-mode ultrasound to the extent of coronary atherosclerosis. Arterioscler Thromb. 1991;11:1786-1794.
10. Adams MR, Nagakomi A, Keech A, Robinson J, McCredie R, Bailey BP, Freedman SB, Celermajer DS. Carotid intima-media thickness is only weakly correlated with the extent and severity of coronary heart disease. Circulation. 1995;92:2127-2134.
11. Yamasaki Y, Kawamori R, Matsushima H, Nishizawa H, Kodama M, Kajimoto Y, Morishima T, Kamada T. Atherosclerosis in carotid artery of young IDDM patients monitored by ultrasound high-resolution B-mode imaging. Diabetes. 1994;43:634-639.
12. Folsom AR, Eckfeldt JH, Weitzman S, Ma J, Chambless LE, Barnes RW, Cram KB, Hutchinson RG, for the Atherosclerosis Risk in Communities (ARIC) Study Investigators. Relation of carotid artery wall thickness to diabetes mellitus, fasting glucose and insulin, body size, and physical activity. Stroke. 1994;25:66-73.
13. Yamasaki Y, Kawamori R, Matsushima H, Nishizawa H, Kodama M, Kubota M, Kajimoto Y, Kamada T. Asymptomatic hyperglycemia is associated with increased intimal plus medial thickness of the carotid artery. Diabetologia. 1995;38:585-591.
14. Uusitupa M, Siitonen O, Aro A, Pyörälä K. Prevalence of coronary heart disease, left ventricular failure and hypertension in middle-aged, newly diagnosed type 2 (non-insulin-dependent) diabetic subjects. Diabetologia. 1985;28:22-27.
15. Niskanen LK, Uusitupa MI, Sarlund H, Siitonen O, Pyörälä K. Five-year follow-up study on plasma insulin levels in newly diagnosed NIDDM patients and nondiabetic subjects. Diabetes Care. 1990;13:41-48.
16. World Health Organization Expert Committee. Second Report on Diabetes Mellitus. Geneva, Switzerland: World Health Organization; 1980. Tech Rep Ser 646.
17. Rose GA, Blackburn H. Cardiovascular Survey Methods, 1968. Geneva, Switzerland: World Health Organization; 1968. WHO Monograph Series No 56.
18. Töyry JP, Niskanen LK, Länsimies EA, Partanen KPL, Uusitupa MIJ. Autonomic neuropathy predicts the development of stroke in patients with non-insulin-dependent diabetes mellitus. Stroke. 1996;27:1316-1318.
19. Bowsher RR, Wolny JD, Frank BH. A rapid and sensitive immunoassay for the measurement of proinsulin in human serum. Diabetes. 1992;41:1084-1090.
20. Haffner SM, Mykkänen L, Stern MP, Valdez RA, Heisserman JA, Bowsher RR. Relationship of proinsulin and insulin to cardiovascular risk factors in non-diabetic subjects. Diabetes. 1993;42:1297-1302.
21. Penttilä IM, Voutilainen E, Laitinen O, Juutilainen P. Comparison of different analytical and precipitation methods for the direct estimation of high-density lipoprotein. Scand J Clin Lab Invest. 1981;41: 353-360.
22. Fruchart J-C, Kora J, Cachera C, Clavey V, Duthilleul P, Moschetto Y. Simultaneous measurement of plasma apolipoproteins A1 and apoB by electroimmunoassay. Clin Chem. 1982;28:59.
23. Rauramaa R, Väisanen S, Mercuri M, Rankinen T, Penttilä I, Bond MG. Association of risk factors and body iron status to carotid atherosclerosis in middle-aged Eastern Finnish men. Eur Heart J. 1994;15:1020-1027.
24. Spencer MP, Reid JM. Quantitation of carotid stenosis with continuous-wave (C-W) Doppler ultrasound. Stroke. 1979;10: 326-330.
25. Tuomilehto J, Arstila M, Kaarsalo E, Kankaanpää J, Ketonen M, Kuulasmaa K, Lehto S, Miettinen H, Mustaniemi H, Palomäki P, Puska P, Pyörälä K, Salomaa V, Torppa J, Vuorenmaa T. Acute myocardial infarction (AMI) in Finland: baseline data from the FINMONICA AMI register in 1983-1985. Eur Heart J. 1992; 13:577-587.
26. Moore JE, Xu C, Glagov S, Zarins S, Ku DN. Fluid wall shear stress measurement in a model of the human abdominal aorta: oscillatory behaviour and relationship to atherosclerosis. Atherosclerosis. 1994;110:225-240.
27. Prati P, Vanuzzo D, Casaroli M, DiChiara A, De Biasi F, Ferulgio GA, Touboul P-J. Prevalence and determinants of carotid atherosclerosis in a general population. Stroke. 1992;23:1705-1711.
28. Tell GS, Polak JF, Ward BJ, Kittner SJ, Savage PJ, Robbins J, for the Cardiovascular Health Study (CHS) Collaborative Research Group. Relation of smoking with carotid wall thickness and stenosis in older adults: the Cardiovascular Health Study. Circulation. 1994;90:2905-2908.
29. Willeit J, Kiechl S. Prevalence and risk factors of asymptomatic extracranial carotid artery atherosclerosis: a population-based study. Arterioscler Thromb. 1993;13:661-668.
30. Sharrett AR, Patsch W, Sorlie PD, Heiss G, Bond MG, Davis CE, for the Atherosclerosis Risk in Communities Investigators. Associations of lipoprotein cholesterols, apolipoproteins A-1 and B. and triglycerides with carotid atherosclerosis and coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb. 1994;14:1098-1104.
31. Eisenberg S. Plasma lipoprotein interconversion. Ann N Y Acad Sci, 1980;348:30-47.
32. Hoff HF, Heideman CL, Gaubatz JW, Gotto AM, Erickson EE, Jackson RL. Quantification of apolipoprotein B in grossly normal aorta. Circ Res. 1977;40:56-64.
33. Ylä-Herttuala S, Jaakkola O, Ehnholm C, Tikkanen MJ, Solakivi T, Särkioja T, Nikkari T. Characterization of two lipoproteins containing apolipoproteins B and E from lesion-free human aortic intima. J Lipid Res. 1988;29:563-572.
34. Simpson HCR, Meade TW, Stirling Y, Mann JI, Chakrabarti R, Woolf L. Hypertriglyceridemia and hypercoagulability. Lancet. 1983;1:786-790.
35. Pyörälä K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care. 1979;2:131-141.
36. Ducimetiere P, Eschwege E, Papoz L, Richard JL, Claude JR, Rosselin G. Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia. 1980;19:205-210.
37. Welborn TA, Wearne K. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentration. Diabetes Care. 1979;2:154-160.
38. Laakso M, Sarlund H, Salonen R, Suhonen M, Pyörälä K, Salonen JT, Karhapää P. Asymptomatic atherosclerosis and insulin resistance. Arterioscler Thromb. 1991;11:1068-1076.
39. Welin L, Eriksson H, Larsson B, Ohlson LO, Svärsudd K. Tibblin G. Hyperinsulinemia is not a risk factor in elderly men: the study of men born in 1913. Diabetologia. 1992;35:766-770.
40. Ferrara A, Barrett-Connor E, Edelstein SL. Hyperinsulinemia does not increase the risk of fatal cardiovascular disease in elderly men or women without diabetes: the Rancho Bernardo Study, 1984 to 1991. Am J Epidemiol. 1994;140:857-869.
41. Nagi DK, Hendra TJ, Ryle AJ, Cooper TM, Temple RC, Clark PM, Schneider AE, Hales CN, Yudkin JS. The relationship of concentrations of insulin, intact proinsulin, and 32-33 split proinsulin with cardiovascular risk factors in type 2 (non-insulin-dependent) diabetic subjects. Diabetologia. 1990;33:532-537.
42. Hales CN. The pathogenesis of NIDDM. Diabetologia. 1994;37 (suppl 2):S162-S168.